On Thursday, Progyny Inc (PGNY) stock saw a decline, ending the day at $15.55 which represents a decrease of $-0.31 or -1.95% from the prior close of $15.86. The stock opened at $15.84 and touched a ...
In a report released yesterday, Faisal Khurshid from Leerink Partners reiterated a Buy rating on Kymera Therapeutics (KYMR – Research ...
On Thursday, Certara Inc (CERT) stock saw a decline, ending the day at $10.12 which represents a decrease of $-0.42 or -3.98% from the prior close of $10.54. The stock opened at $10.56 and touched a ...
The French drugmaker’s newly launched respiratory syncytial virus antibody Beyfortus far exceeded analyst expectations, ...
Pfizer and Merck's pneumococcal vaccines have been recommended for adults aged 50 and over in the US, potentially opening up ...
Still, Labcorp, cut the top-end of its 2024 adjusted profit forecast to $14.70 per share from $14.90, due to an impact of ...
EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares ...
Leerink Partners analyst Jonathan Chang maintained a Buy rating on Molecular Partners (MOLN – Research Report) on October 22. The ...
16h
Shares of Theravance Biopharma, Inc. (NASDAQ:TBPH – Get Free Report) have been given a consensus recommendation of “Hold” by ...
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company ...
Read more: Swiss healthcare partners clinch new tariff system with flat rates This content was published on Oct 23, 2024 The International Monetary Fund has revised Switzerland’s growth forecast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback